Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Treasury Shares (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Treasury Shares for 2 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $952000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $952000.0, a 0.0% change, with the full-year FY2024 number at $952000.0, changed 0.0% from a year prior.
  • Treasury Shares was $952000.0 for Q3 2025 at Precision Biosciences, roughly flat from $952000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $952000.0 in Q1 2021 to a low of $952000.0 in Q1 2021.
  • A 5-year average of $952000.0 and a median of $952000.0 in 2021 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 0.0% in 2021; the steepest drop was 0.0% in 2021.
  • Precision Biosciences' Treasury Shares stood at $952000.0 in 2021, then changed by 0.0% to $952000.0 in 2022, then changed by 0.0% to $952000.0 in 2023, then changed by 0.0% to $952000.0 in 2024, then changed by 0.0% to $952000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Treasury Shares are $952000.0 (Q3 2025), $952000.0 (Q2 2025), and $952000.0 (Q1 2025).